NKAP-like protein (NKAPL)

NKAP-like protein (NKAPL) is a poorly characterized human protein encoded by the NKAPL gene (also known as C6orf194 and bA424I5.1). It is named due to its sequence similarity to NKAP (NF-κB activating protein), but it is not itself known to activate NF-κB or function as a therapeutic target. NKAP is a transcriptional repressor involved in T cell development and Notch signaling; however, currently there is no evidence that NKAPL is functionally equivalent or that it plays a direct role in canonical NF-κB signaling or in pathogenesis of common diseases. NKAPL's biological role remains unclear, and there is a lack of data supporting drug interactions, specific molecular mechanism, or clinical biomarker utility. The target is not a therapeutic target or receptor, enzyme, transporter, etc., based on the current literature. Most information relates to the gene and protein's existence and homology to NKAP, with a lack of functional data or disease association. If you meant "NF-κB activating protein" (NKAP) instead, that is a well-studied transcriptional regulator involved in immune function, but "NKAP-like" (NKAPL) is distinct, uncharacterized, and not validated as a drug target. There is no evidence NKAPL is a receptor or a clinically actionable molecular target at this time.

Other names

NKAPLNKAP-like proteinC6orf194bA424I5.1